SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-051434
Filing Date
2023-04-27
Accepted
2023-04-27 16:43:14
Documents
7
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231903-2_def14a.htm DEF 14A 1056497
2 GRAPHIC bc_capvsnetincome-4c.jpg GRAPHIC 126372
3 GRAPHIC bc_capvstsr-4c.jpg GRAPHIC 119022
4 GRAPHIC ic_arrow-bw.jpg GRAPHIC 3263
5 GRAPHIC ic_men-bw.jpg GRAPHIC 2120
6 GRAPHIC px_proxypg3-bw.jpg GRAPHIC 766227
7 GRAPHIC px_proxypg4-bw.jpg GRAPHIC 576215
  Complete submission text file 0001104659-23-051434.txt   2973331
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38492 | Film No.: 23857897
SIC: 2834 Pharmaceutical Preparations